Li, H.; Su, H.; Komori, A.; Yang, S.; Luo, H.; Yang, A.W.H.; Sun, X.; Li, H.; Hung, A.; Zhao, X.
Supercomputing Multi-Ligand Modeling, Simulation, Wavelet Analysis and Surface Plasmon Resonance to Develop Novel Combination Drugs: A Case Study of Arbidol and Baicalein Against Main Protease of SARS-CoV-2. Pharmaceuticals 2025, 18, 1054.
https://doi.org/10.3390/ph18071054
AMA Style
Li H, Su H, Komori A, Yang S, Luo H, Yang AWH, Sun X, Li H, Hung A, Zhao X.
Supercomputing Multi-Ligand Modeling, Simulation, Wavelet Analysis and Surface Plasmon Resonance to Develop Novel Combination Drugs: A Case Study of Arbidol and Baicalein Against Main Protease of SARS-CoV-2. Pharmaceuticals. 2025; 18(7):1054.
https://doi.org/10.3390/ph18071054
Chicago/Turabian Style
Li, Hong, Hailong Su, Akari Komori, Shuxuan Yang, Hailang Luo, Angela Wei Hong Yang, Xiaomin Sun, Hongwei Li, Andrew Hung, and Xiaoshan Zhao.
2025. "Supercomputing Multi-Ligand Modeling, Simulation, Wavelet Analysis and Surface Plasmon Resonance to Develop Novel Combination Drugs: A Case Study of Arbidol and Baicalein Against Main Protease of SARS-CoV-2" Pharmaceuticals 18, no. 7: 1054.
https://doi.org/10.3390/ph18071054
APA Style
Li, H., Su, H., Komori, A., Yang, S., Luo, H., Yang, A. W. H., Sun, X., Li, H., Hung, A., & Zhao, X.
(2025). Supercomputing Multi-Ligand Modeling, Simulation, Wavelet Analysis and Surface Plasmon Resonance to Develop Novel Combination Drugs: A Case Study of Arbidol and Baicalein Against Main Protease of SARS-CoV-2. Pharmaceuticals, 18(7), 1054.
https://doi.org/10.3390/ph18071054
